5-HT2A: Its role in frontally mediated executive function and related psychopathology

CNS Spectrums

Volumn 12, Issue 7, 2007, Pages 512-516

  Stein, Dan J ^a,b   Hemmings, Sian ^c   Moolman Smook, Hanlie ^c   Audenaert, Kurt ^d  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c STELLENBOSCH UNIVERSITY   (South Africa)

^d GHENT UNIVERSITY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; GLUCOCORTICOID; MIANSERIN; MIRTAZAPINE; NEFAZODONE; SEROTONIN 2A RECEPTOR; SEROTONIN 2B RECEPTOR; SEROTONIN 2C RECEPTOR; SEROTONIN UPTAKE INHIBITOR; TRAZODONE;

ALLELE; ARTICLE; BINDING SITE; CASE REPORT; CLINICAL FEATURE; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG MECHANISM; DRUG WITHDRAWAL; GENE EXPRESSION; GENETIC VARIABILITY; GENOTYPE; HUMAN; IMPULSIVENESS; LIVER TOXICITY; MALE; MENTAL DISEASE; PESSIMISM; PRIORITY JOURNAL; RECURRENT DISEASE; RISK FACTOR; SEXUAL DYSFUNCTION; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; UPREGULATION; ATTITUDE; COGNITIVE DEFECT; FRONTAL LOBE; MAJOR DEPRESSION; MENTAL STRESS; METABOLISM; PATHOPHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; PSYCHOLOGICAL ASPECT;

ATTITUDE; COGNITION DISORDERS; DEPRESSIVE DISORDER, MAJOR; FRONTAL LOBE; HUMANS; MALE; POSITRON-EMISSION TOMOGRAPHY; RECEPTOR, SEROTONIN, 5-HT2A; SEROTONIN UPTAKE INHIBITORS; STRESS, PSYCHOLOGICAL; TRAZODONE;

EID: 34547571552     PISSN: 10928529     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1092852900021246     Document Type: Article

References (50)

1. Barnes NM, Sharp T. A review of central 5-HT receptors and their function. Neuropharmacology. 1999;38:1083-1152.
2. Celada P, Puig M, Amargós-Bosch M, Adell A, Artigas F. The therapeutic role of 5-HT1A and 5-HT2A receptors in depression. J Psychiatry Neurosci. 2004;29:252-265.
3. Roth BL, Willins DL, Kristiansen K, Kroeze WK. 5-Hydroxytryptamine2- family receptors (5-hydroxytryptamine2A, 5-hydroxytryptamine2B, 5-hydroxytryptamine2C): where structure meets function. Pharmacol Ther. 1998;79:231-257.
4. Winstanley CA, Theobald DE, Dalley JW, Glennon JC, Robbins TW. 5-HT2A and 5-HT2C receptor antagonists have opposing effects on a measure of impulsivity: interactions with global 5-HT depletion. Psychopharmacology (Berl). 2004;176:376-385.
5. Marek GJ, Carpenter LL, McDougle CJ, Price LH. Synergistic action of 5-HT2A antagonists and selective serotonin reuptake inhibitors in neuropsychiatry disorders. Neuropsychopharmacology 2003;28:402-412.
6. Chen K, Yang W, Grimsby J, Shih JC. The human 5-HT2 receptor is encoded by a multiple intron-exon gene. Brain Res Mol Brain Res. 1992;14:20-26.
7. Li D, Duan Y, He L. Association study of serotonin 2A receptor (5-HT2A) gene with schizophrenia and suicidal behavior using systematic meta-analysis. Biochem Biophys Res Commun. 2006;340:1006-1015.
8. Van Oekelen D, Luyten WH, Leysen JE. 5-HT2A and 5-HT2C receptors and their atypical regulation properties. Life Sci. 2003;72:2429-2449.
9. Williams GV, Rao SG, Goldman-Rakic PS. The physiological role of 5-HT2A receptors in working memory. J Neurosci. 2002;22:2843-2854.
10. Passetti F, Dalley JW, Robbins TW. Double dissociation of serotonergic and dopaminergic mechanisms on attentional performance using a rodent five-choice reaction time task. Psychopharmacology (Berl). 2003;165:136-145.
11. Gonzalez-Maeso J, Weisstaub NV, Zhou M, et al. Hallucinogens recruit specific cortical 5-HT2A receptor-mediated signaling pathways to affect behavior. Neuron. 2007;53:439-452.
12. Blier P, Szabo ST. Potential mechanisms of action of atypical antipsychotics in treatment-resistant depression and anxiety. J Clin Psychiatry. 2005;66(suppl 8):30-40.
13. Stockmeier C, Kellar K. In vivo regulation of the serotonin-2 receptor in rat brain. Life Sci. 1986;38:117-127.
14. Preece MA, Dalley JW, Theobald DE, Robbins TW, Reynolds GP. Region specific changes in forebrain 5-hydroxytryptamine1A and 5-hydroxytryptamine2A receptors in isolation-reared rats: an in vitro autoradiography study. Neuroscience. 2004;123:725-732.
15. Katagiri H, Kagaya A, Nakae S, Morinobu S, Yamawaki S. Modulation of serotonin2a receptor function in rats after repeated treatment with dexamethasone and L-type calcium channel antagonist nimodipine. Prog Neuropsychopharmacol Biol Psychiatry. 2001;25:1269-1281.
16. Meyer JH, McMain S, Kennedy SH, et al. Dysfunctional attitudes and 5-HT2 receptors during depression and self-harm. Am J Psychiatry. 2003;160:90-99.
17. Bhagwagar Z, Hinz R, Taylor M, Fancy S, Cowen P, Grasby PJ. Increased 5-HT2A receptor binding in euthymic, medication-free patients recovered from depression: a positron emission study with [11C]MDL 100,907. Am J Psychiatry. 2006;163:1580-1587.
18. Yates M, Leake A, Candy JM, Fairbairn AF, McKeith IG, Ferrier IN. 5HT2 changes in major depression. Biol Psychiatry. 1990;27:489-496.
19. Oquendo MA, Russo SA, Underwood MD, et al. Higher postmortem prefrontal 5-HT2A receptor binding correlates with lifetime aggression in suicide. Biol Psychiatry. 2006;59:235-243.
20. Turecki G, Brie R, Dewar K, et al. Prediction of level of serotonin 2A receptor binding by serotonin receptor 2A genetic variation in postmortem brain samples from subjects who did or did not commit suicide. Am J Psychiatry. 1999;156:1456-1458.
21. Meyer JH, Kapur S, Eisfeld B, et al. The effect of paroxetine on 5-HT(2A) receptors in depression: an [(18)F]setoperone PET imaging study. Am J Psychiatry. 2001;158:78-85.
22. van Heeringen C, Audenaert K, Van Laere K, et al. Prefrontal 5-HT2a receptor binding index, hopelessness and personality characteristics in attempted suicide. J Affect Disord. 2003;74:149-158.
23. Biver F, Wikler D, Lotstra F, Damhaut P, Goldman S, Mendlewicz J. Serotonin 5-HT2 receptor imagingin major depression: focal changes in orbito-insular cortex. Br J Psychiatry. 1997;171:444-448.
24. Yatham LN, Liddle PF, Shiah IS, et al. Brain serotonin2 receptors in major depression: a positron emission tomography study. Arch Gen Psychiatry. 2000;57:850-858.
25. Mintun MA, Sheline YI, Moerlein SM, Vlassenko AG, Huang Y, Snyder AZ. Decreased hippocampal 5-HT2A receptor binding in major depressive disorder: in vivo measurement with [18F]altanserin positron emission tomography. Biol Psychiatry. 2004;55:217-224.
26. Stockmeier CA. Involvement of serotonin in depression: evidence from postmortem and imaging studies of serotonin receptors and the serotonin transporter. J Psychiatr Res. 2003;37:357-373.
27. Amat J, Paul E, Zarza C, Watkins LR, Maier SF. Previous experience with behavioral control over stress blocks the behavioral and dorsal raphe nucleus activating effects of later uncontrollable stress: role of the ventral medial prefrontal cortex. J Neurosci. 2006;26:13264-13272.
28. Yatham LN, Liddle PF, Dennie J, et al. Decrease in brain serotonin 2 receptor binding in patients with major depression following desipramine treatment: a positron emission tomography study with fluorine-18-labeled setoperone. Arch Gen Psychiatry. 1999;56:705-711.
29. Yatham LN, Liddle PR Shiah IS, et al. Effects of rapid tryptophan depletion on brain 5-HT(2) receptors: a PET study. Br J Psychiatry. 2001;178:448-453.
30. El Mansari M, Blier P. Responsiveness of 5-HT1A and 5-HT2 receptors in the rat orbitofrontal cortex after long-term serotonin reuptake inhibition. J Psychiatry Neurosci. 2005;30:268-274.
31. Polesskaya OO, Sokolov BP. Differential expression of the C and T alleles of the 5-HT2A receptor gene in the temporal cortex of normal individuals and schizophrenics. J Neurosci Res. 2002;67:812-822.
32. Parsons MJ, D'Souza UM, Arranz MJ, Kerwin RW, Makoff AJ. The -1438A/G polymorphism in the 5-hydroxytryptamine type 2A receptor gene affects promoter activity. Biol Psychiatry. 2004;56:406-410.
33. Kouzmenko AP. No correlation between A(-1438)G polymorphism in 5-HT2A receptor gene promoter and the density of frontal cortical 5-HT2A receptors in schizophrenia. Hum Hered. 2007;49:103-105.
34. Bray NJ, Buckland PR, Hall H, Owen MJ, O'Donovan MC. The serotonin-2A receptor gene locus does not contain common polymorphism-affecting mRNA levels in adult brain. Mol Psychiatry. 2004;9:109-114.
35. Bjork JM, Moeller FG, Dougherty DM, Swann AC, Machado MA, Hanis CL. Serotonin 2a receptor T102C polymorphism and impaired impulse control. Am J Med Genet. 2002;114:336-339.
36. Hemmings SM, Kinnear CJ, Lochner C, et al. Genetic correlates in trichotillomania - a case-control association study in the South African Caucasian population. Isr J Psychiatry Relat Sci. 2006;43:93-101.
37. Bonnier B, Gorwood P, Hamon P, Sarfati Y, Boni C, Hardy-Bayle MC. Association of 5-HT2A receptor gene polymorphism with major affective disorders: the case of a subgroup of bipolar disorder with low suicide risk. Biol Psychiatry. 2002;51:762-765.
38. Berggård C, Damberg M, Longato-Stadler E, Hallman J, Oreland L, Garpenstrand H. The serotonin 2A -1438 G/A receptor polymorphism in a group of Swedish male criminals. Neurosci Lett. 2003;347:196-198.
39. Ricca V, Nacmias B, Boldrini M, et al. Psychopathological traits and 5-HT2A receptor promoter polymorphism (-1438 G/A) in patients suffering from anorexia nervosa and bulimia nervosa. Neurosci Lett. 2004;365:92-96.
40. Nomura M, Nomura Y. Psychological, neuroimaging, and biochemical studies on functional association between impulsive behavior and the 5-HT2A receptor gene polymorphism in humans. Ann N Y Acad Sci. 2006;1086:134-143.
41. De Luca V, Likhodi O, Kennedy JL, Wong AH. Parent-of-origin effect and genomic imprinting of the HTR2A receptor gene T102C polymorphism in psychosis. Psychiatry Res. 2007;151:243-248.
42. Gerard MS, Higley JD. Evolutionary underpinnings of excessive alcohol consumption. Addiction. 2002;97:415-425.
43. Peremans K, Audenaert K, Hoybergs Y, et al. The effect of citalopram hydrobromide on 5-HT2A receptors in the impulsive-aggressive dog, as measured with 1231-5-1-R91150SPECT. Eur J Nucl Med Mol Imaging. 2005;32:708-716.
44. Kendler KS. Reflections on the relationship between psychiatric genetics and psychiatric nosology. Am J Psychiatry. 2006;163:1138-1146.
45. Lerer B, Segman RH, Tan EC, et al. Combined analysis of 635 patients confirms an age-related association of the serotonin 2A receptor gene with tardive dyskinesia and specificity for the non-orofacial subtype. Int J Neuropsychopharmacol. 2005;8:411-425.
46. Arranz MJ, Munro J, Sham P, et al. Meta-analysis of studies on genetic variation in 5-HT2A receptors and clozapine response. Schizophr Res. 1998;32:93-99.
47. Papakostas GI, Fava M. A meta-analysis of clinical trials comparing the serotonin (5HT)-2 receptor antagonists trazodone and nefazodone with selective serotonin reuptake inhibitors for the treatment of major depressive disorder. Eur Psychiatry. In press.
48. Stein DJ, Newman TK, Savitz J, Ramesar R. Warriors versus worriers: the role of COMT gene variants. CNS Spectr. 2006;11:745-748.
49. Alex KD, Pehek EA. Pharmacologic mechanisms of serotonergic regulation of dopamine neurotransmission. Pharmacol Ther. 2007;113:296-320.
50. Harvey BH, Naciti C, Brand L, Stein DJ. Endocrine, cognitive and hippocampal/cortical 5HT 1A/2A receptor changes evoked by a time-dependent sensitisation (TDS) stress model in rats. Brain Res. 2003;983:97-107.